NEW YORK — Fenwick announced today that Roger Cohen has joined the firm as a partner in its New York office and healthcare regulatory practice.
Fenwick represented Lycia Therapeutics, Inc. (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery ...
Fenwick today announced the election of five lawyers to its partnership, effective January 1, 2027.
Nov.–Dec. 2026: Lame-duck session; the KIDS Act, GUARD Act, and the Senate Commerce Committee’s kids’ online safety and chatbot bills await Senate action, and House and Senate negotiators may ...
LA Tech Week made one thing clear: hard tech is now a core part of Tech Week. About one in seven events on the LA calendar addressed the topic, and Fenwick hosted and joined several of them. Here are ...
Fenwick represented Alta, an AI-powered fashion styling platform, in its $20 million Series A funding. The round was led by ...
Fenwick has submitted a comment letter responding to the SEC’s request for creative ideas to modernize the initial public offering process. The letter addresses frictions that may discourage companies ...
Each year, Fenwick publishes the SV 150 List and a Proxy Season report comparing stockholder voting results between SV 150 companies and companies comprising the Standard & Poor’s 100 Index.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results